Tissue-Growing Device for Short Bowel Syndrome
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT05535361
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
Phase: N/A
Role: Lead Sponsor
Start: Sep 15, 2025
Completion: Jun 30, 2028
Loading map...